APTV
NEUTRAL
$76.47
Live
Aptiv PLC · NYSE
Target $101.81
(+33.1%)
$47.19
52W Range
$88.93
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$16.65B
P/E
58.82
ROE
3.3%
Profit margin
1.5%
Debt/Equity
0.85
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
72%
The deterministic health scores present a mixed picture: the Piotroski F-Score of 4/9 indicates stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a high current P/E of 58.82, the forward P/E of 9.01 suggests strong earnings growth expectations. The company beats earnings estimates consistently, with a 3/4 beat rate over the last four quarters and an average surprise of 14.89%, yet insider selling and weak long-term price performance raise caution. While analysts are bullish with a $101.81 target price and a 'buy' recommendation, the stock trades at a significant premium to the Graham Number of $35.41, implying high valuation risk.
Key Strengths
Consistent earnings beat rate (3 out of last 4 quarters) with strong average surprise of 14.89%
Robust year-over-year EPS growth of 18.6% and revenue growth of 7.40%
Forward P/E of 9.01 indicates strong future earnings expectations relative to current P/E of 58.82
Solid balance sheet with Current Ratio of 1.79 and Quick Ratio of 1.22
Debt/Equity of 0.85 is below sector average of 1.60, indicating conservative leverage
Key Risks
Piotroski F-Score of 4/9 suggests only moderate financial health, limiting confidence in stability
Current P/E of 58.82 is significantly above forward P/E and sector average, indicating potential overvaluation
Stock trades at more than double the Graham Number ($35.41) and well above intrinsic value estimate of $9.10
Insider selling activity: $7.52M in sales over last 6 months with zero buys, signaling bearish sentiment
5-year price return of -45.0% reflects prolonged underperformance despite recent 1-year rebound
AI Fair Value Estimate
Based on comprehensive analysis
$68.5
-10.4% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
52
Moderate
42
78
58
60
20
AI Verdict
Cautiously optimistic with valuation and insider risk
Key drivers: Strong forward earnings expectations, Consistent earnings outperformance, Low leverage relative to peers, High current valuation, Bearish insider activity
Confidence
75%
Value
42/100
Ref P/E, PEG, Graham Number
Positives
- Forward P/E of 9.01 is attractive
- Price/Sales of 0.83 is below 1.0, suggesting possible revenue-based value
Watchpoints
- Current P/E of 58.82 is extremely high
- Stock trades at over 2x Graham Number ($35.41)
- Intrinsic value estimate of $9.10 is far below current price
Future
78/100
Ref Growth rates
Positives
- YoY EPS growth of 18.6%
- Revenue growth of 7.40% in line with sector
- Forward P/E implies strong earnings improvement
Watchpoints
- PEG Ratio unavailable limits growth-adjusted valuation
Past
58/100
Ref Historical trends
Positives
- History of beating earnings estimates (20 of last 25 quarters positive surprises)
- Recent quarters show accelerating EPS growth
Watchpoints
- 5-year price return of -45.0% indicates long-term underperformance
- Volatility in earnings, including a -63.6% miss in Q3 2022
Health
60/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 4/9 indicates stable financial condition
- Current Ratio (1.79) and Quick Ratio (1.22) show adequate liquidity
- Debt/Equity of 0.85 is below sector average of 1.60
Watchpoints
- Piotroski score below 7 indicates lack of financial strength
- Altman Z-Score not available, creating uncertainty in bankruptcy risk assessment
Dividend
20/100
Ref Yield, Payout
Positives
- Payout ratio of 0.00% allows full reinvestment
Watchpoints
- No dividend yield reported
- Dividend Strength score of 0/100 indicates no income appeal
- No history of dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$76.47
Analyst Target
$101.81
Upside/Downside
+33.1%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for APTV and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
APTV
Aptiv PLC
Primary
|
-45.0% | -27.9% | +19.6% | +7.8% | -0.4% | -2.7% |
|
XPEV
XPeng Inc.
Peer
|
-53.7% | +54.0% | -17.4% | -26.9% | +0.7% | -9.3% |
|
HTHT
H World Group Limited
Peer
|
+7.9% | +17.3% | +68.5% | +41.1% | +0.8% | +0.5% |
|
BALL
Ball Corporation
Peer
|
-32.0% | +4.9% | +5.6% | -2.0% | +9.7% | +2.3% |
|
H
Hyatt Hotels Corporation
Peer
|
+99.6% | +45.4% | +46.0% | +10.3% | +15.2% | -5.0% |
APT
Aptiv PLC
Primary
5Y
-45.0%
3Y
-27.9%
1Y
+19.6%
6M
+7.8%
1M
-0.4%
1W
-2.7%
XPE
XPeng Inc.
Peer
5Y
-53.7%
3Y
+54.0%
1Y
-17.4%
6M
-26.9%
1M
+0.7%
1W
-9.3%
HTH
H World Group Limited
Peer
5Y
+7.9%
3Y
+17.3%
1Y
+68.5%
6M
+41.1%
1M
+0.8%
1W
+0.5%
BAL
Ball Corporation
Peer
5Y
-32.0%
3Y
+4.9%
1Y
+5.6%
6M
-2.0%
1M
+9.7%
1W
+2.3%
H
Hyatt Hotels Corporation
Peer
5Y
+99.6%
3Y
+45.4%
1Y
+46.0%
6M
+10.3%
1M
+15.2%
1W
-5.0%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
58.82
Forward P/E
9.01
PEG Ratio
N/A
P/B Ratio
1.78
P/S Ratio
0.83
EV/Revenue
1.16
EV/EBITDA
7.28
Market Cap
$16.65B
Profitability
Profit margins and return metrics
Profit Margin
1.46%
Operating Margin
11.43%
Gross Margin
19.41%
ROE
3.29%
ROA
5.77%
Growth
Revenue and earnings growth rates
Revenue Growth
+7.4%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.85
Moderate
Current Ratio
1.79
Good
Quick Ratio
1.22
Good
Cash/Share
$7.59
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-02
$N/A
2025-10-30
$2.17
+18.8% surprise
2025-07-31
$2.12
+15.8% surprise
2025-05-01
$1.69
+10.1% surprise
Consumer Cyclical Sector Comparison
Comparing APTV against 386 companies in the Consumer Cyclical sector
(23 bullish, 133 neutral, 230 bearish)
P/E Ratio
58.82
This Stock
vs
33.98
Sector Avg
+73.1%
(Expensive)
Return on Equity (ROE)
3.29%
This Stock
vs
-43.92%
Sector Avg
-107.5%
(Below Avg)
Profit Margin
1.46%
This Stock
vs
-5.4%
Sector Avg
-127.1%
(Weaker)
Debt to Equity
0.85
This Stock
vs
1.51
Sector Avg
-43.5%
(Less Debt)
Revenue Growth
7.4%
This Stock
vs
28.42%
Sector Avg
-74.0%
(Slower)
Current Ratio
1.79
This Stock
vs
2.46
Sector Avg
-27.0%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
APTV
Aptiv PLC
|
NEUTRAL | $16.65B | 58.82 | 3.3% | 1.5% | $76.47 | |
|
XPEV
XPeng Inc.
|
BEARISH | $16.35B | - | -3.7% | -1.5% | $17.11 | Compare |
|
HTHT
H World Group Limited
|
BULLISH | $16.15B | 22.52 | 40.5% | 20.1% | $52.48 | Compare |
|
BALL
Ball Corporation
|
NEUTRAL | $15.61B | 21.89 | 11.7% | 5.4% | $57.36 | Compare |
|
H
Hyatt Hotels Corporation
|
NEUTRAL | $15.49B | - | -1.3% | -1.5% | $163.96 | Compare |
APTV
Aptiv PLC
NEUTRAL
Mkt Cap
$16.7B
P/E
58.8
ROE
3.3%
Price
$76.47
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-08 | RAMUNDO KATHERINE HARGROVE | Chief Operating Officer | Sale | 5,000 | $425,000 |
| 2025-12-12 | LAROYIA VARUN | Chief Financial Officer | Sale | 5,000 | $400,250 |
| 2025-12-12 | CLARK KEVIN P | Chief Executive Officer | Gift | 25,320 | - |
| 2025-12-12 | AGNEVALL HAKAN | Director | Purchase | 3,700 | $296,918 |
| 2025-12-10 | AGNEVALL HAKAN | Director | Stock Award | 955 | - |
| 2025-12-05 | MAHONEY SEAN O | Director | Sale | 7,881 | $603,685 |
| 2025-12-04 | LAROYIA VARUN | Chief Financial Officer | Sale | 14,500 | $1,129,260 |
| 2025-11-12 | MAHONEY SEAN O | Director | Gift | 310 | - |
| 2025-11-10 | RAMUNDO KATHERINE HARGROVE | Officer | Sale | 13,000 | $1,092,000 |
| 2025-09-18 | BRAZIER ALLAN J | Officer | Sale | 1,000 | $85,000 |
| 2025-08-26 | BRAZIER ALLAN J | Officer | Sale | 6,539 | $523,120 |
| 2025-08-26 | LOUISSAINT OBED D | Officer | Sale | 3,000 | $240,000 |
| 2025-08-21 | MASSARO JOSEPH R | Officer | Sale | 35,000 | $2,602,600 |
| 2025-08-18 | LOUISSAINT OBED D | Officer | Sale | 1,500 | $112,500 |
| 2025-08-12 | LOUISSAINT OBED D | Officer | Sale | 1,500 | $105,000 |
RAMUNDO KATHERINE HARGROVE
Chief Operating Officer
2026-01-08
5,000 shares
·
$425,000
LAROYIA VARUN
Chief Financial Officer
2025-12-12
5,000 shares
·
$400,250
CLARK KEVIN P
Chief Executive Officer
2025-12-12
25,320 shares
AGNEVALL HAKAN
Director
2025-12-12
3,700 shares
·
$296,918
AGNEVALL HAKAN
Director
2025-12-10
955 shares
MAHONEY SEAN O
Director
2025-12-05
7,881 shares
·
$603,685
LAROYIA VARUN
Chief Financial Officer
2025-12-04
14,500 shares
·
$1,129,260
MAHONEY SEAN O
Director
2025-11-12
310 shares
RAMUNDO KATHERINE HARGROVE
Officer
2025-11-10
13,000 shares
·
$1,092,000
BRAZIER ALLAN J
Officer
2025-09-18
1,000 shares
·
$85,000
BRAZIER ALLAN J
Officer
2025-08-26
6,539 shares
·
$523,120
LOUISSAINT OBED D
Officer
2025-08-26
3,000 shares
·
$240,000
MASSARO JOSEPH R
Officer
2025-08-21
35,000 shares
·
$2,602,600
LOUISSAINT OBED D
Officer
2025-08-18
1,500 shares
·
$112,500
LOUISSAINT OBED D
Officer
2025-08-12
1,500 shares
·
$105,000
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
16 analysts
Oppenheimer
2026-01-21
Outperform
Outperform
UBS
2026-01-14
Neutral
Neutral
Piper Sandler
2026-01-08
Neutral
Overweight
Wells Fargo
2025-12-09
Overweight
Overweight
Morgan Stanley
2025-12-08
Underweight
Equal-Weight
RBC Capital
2025-11-19
Outperform
Outperform
Wells Fargo
2025-10-31
Overweight
Overweight
TD Cowen
2025-10-31
Buy
Buy
Piper Sandler
2025-10-31
Neutral
Neutral
JP Morgan
2025-10-20
Overweight
Overweight
Past News Coverage
Recent headlines mentioning APTV from our newsroom.
Newest → oldest
No matching news yet.